ENDRA Life Sciences (NDRA) Change in Accured Expenses (2016 - 2021)
Historic Change in Accured Expenses for ENDRA Life Sciences (NDRA) over the last 6 years, with Q4 2021 value amounting to -$37693.0.
- ENDRA Life Sciences' Change in Accured Expenses rose 9035.55% to -$37693.0 in Q4 2021 from the same period last year, while for Dec 2021 it was $491104.0, marking a year-over-year increase of 15881.56%. This contributed to the annual value of -$198867.0 for FY2024, which is 7581.45% up from last year.
- Latest data reveals that ENDRA Life Sciences reported Change in Accured Expenses of -$37693.0 as of Q4 2021, which was up 9035.55% from -$65736.0 recorded in Q3 2021.
- In the past 5 years, ENDRA Life Sciences' Change in Accured Expenses ranged from a high of $818065.0 in Q2 2021 and a low of -$390823.0 during Q4 2020
- Its 5-year average for Change in Accured Expenses is $53546.0, with a median of -$51714.5 in 2021.
- Examining YoY changes over the last 5 years, ENDRA Life Sciences' Change in Accured Expenses showed a top increase of 66583.37% in 2019 and a maximum decrease of 126308.32% in 2019.
- Quarter analysis of 5 years shows ENDRA Life Sciences' Change in Accured Expenses stood at $536173.0 in 2017, then crashed by 117.49% to -$93756.0 in 2018, then surged by 665.83% to $530503.0 in 2019, then crashed by 173.67% to -$390823.0 in 2020, then soared by 90.36% to -$37693.0 in 2021.
- Its Change in Accured Expenses stands at -$37693.0 for Q4 2021, versus -$65736.0 for Q3 2021 and $818065.0 for Q2 2021.